Xenon Pharmaceuticals (XENE) Research & Development (2013 - 2026)
Xenon Pharmaceuticals' Research & Development came in at $99.22 million for Q2 2026, up 32.3% from $74.99 million a year earlier and up 12.1% from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xenon Pharmaceuticals reported Research & Development of $352.49 million, up 39.5% year-over-year; for FY2025, it came in at $300.94 million, up 43.0% from FY2024.
- Research & Development has increased in each of the last seven years, with a five-year compound annual growth rate of 42.9% (FY2020 to FY2025).
- Going back by year, Research & Development was $210.39 million in FY2024 (+25.6%), $167.51 million in FY2023 (+58.4%), $105.77 million in FY2022 (+40.2%) and $75.46 million in FY2021 (+49.4%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q3 2013.
- Year-over-year, Research & Development has increased for 31 consecutive quarters, with growth averaging 40.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 12.0% in Q1 2024 to 104.1% in Q1 2023.
- Business Quant data shows XENE's Research & Development at $88.51 million (Q1 2026), $87.7 million (Q4 2025) and $77.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Xenon Pharmaceuticals | 3.55 Bn | 3.55 Bn | - | 99.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.22 Mn |
| Mar 31, 2026 | 88.51 Mn |
| Dec 31, 2025 | 87.70 Mn |
| Sep 30, 2025 | 77.05 Mn |
| Jun 30, 2025 | 74.99 Mn |
| Mar 31, 2025 | 61.20 Mn |
| Dec 31, 2024 | 59.47 Mn |
| Sep 30, 2024 | 56.97 Mn |
| Jun 30, 2024 | 49.70 Mn |
| Mar 31, 2024 | 44.25 Mn |
| Dec 31, 2023 | 41.08 Mn |
| Sep 30, 2023 | 42.88 Mn |
| Jun 30, 2023 | 44.04 Mn |
| Mar 31, 2023 | 39.52 Mn |
| Dec 31, 2022 | 34.83 Mn |
| Sep 30, 2022 | 29.43 Mn |
| Jun 30, 2022 | 22.15 Mn |
| Mar 31, 2022 | 19.36 Mn |
| Dec 31, 2021 | 21.89 Mn |
| Sep 30, 2021 | 18.89 Mn |
API Access
Xenon Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();